INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 94 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 34.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $5,000 | -96.7% | 4,901 | -92.8% | 0.00% | – |
| Q4 2021 | $153,000 | -19.9% | 68,269 | +6.8% | 0.00% | – |
| Q3 2021 | $191,000 | 0.0% | 63,911 | 0.0% | 0.00% | – |
| Q2 2021 | $191,000 | +7.3% | 63,911 | +15.4% | 0.00% | – |
| Q1 2021 | $178,000 | +1171.4% | 55,363 | +722.1% | 0.00% | – |
| Q4 2020 | $14,000 | +1300.0% | 6,734 | +649.1% | 0.00% | – |
| Q1 2019 | $1,000 | -50.0% | 899 | -52.1% | 0.00% | – |
| Q4 2018 | $2,000 | -99.0% | 1,876 | -97.3% | 0.00% | -100.0% |
| Q3 2018 | $191,000 | +1173.3% | 70,516 | +796.9% | 0.00% | – |
| Q2 2018 | $15,000 | -76.2% | 7,862 | -74.2% | 0.00% | -100.0% |
| Q1 2018 | $63,000 | +10.5% | 30,433 | +7.0% | 0.00% | +50.0% |
| Q4 2017 | $57,000 | +612.5% | 28,445 | +320.9% | 0.00% | – |
| Q3 2017 | $8,000 | – | 6,758 | +112533.3% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 6 | -99.8% | 0.00% | – |
| Q4 2016 | $4,000 | – | 3,314 | +3388.4% | 0.00% | – |
| Q3 2016 | $0 | -100.0% | 95 | -93.5% | 0.00% | -100.0% |
| Q3 2015 | $12,000 | -36.8% | 1,462 | -17.3% | 0.00% | -50.0% |
| Q2 2015 | $19,000 | -87.2% | 1,768 | -83.5% | 0.00% | -88.2% |
| Q1 2015 | $149,000 | – | 10,697 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,354,963 | $38,132,000 | 1.80% |
| Orbimed Advisors | 4,520,800 | $73,201,000 | 1.55% |
| QVT Financial LP | 1,326,610 | $21,480,000 | 1.44% |
| BB BIOTECH AG | 1,089,828 | $17,646,000 | 1.27% |
| Meditor Group Ltd | 250,000 | $4,048,000 | 0.55% |
| Perimeter Capital Partners, LLC | 159,915 | $2,589,000 | 0.50% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 156,808 | $2,539,000 | 0.43% |
| Broadfin Capital, LLC | 117,172 | $1,897,000 | 0.37% |
| OXFORD ASSET MANAGEMENT LLP | 811,331 | $13,184,000 | 0.36% |
| Baker Brothers Advisors | 1,016,433 | $16,458,000 | 0.33% |